April 11, 2008

Psychiatrist Bans Sales Reps After Seroquel Reps Visit

Danny Carlat, whom many of you know through his website and his "Dr. Drug Rep" article of last year, is a clinical professor of psychiatry at Tufts University and is in private practice. Anyhow, Carlat recently had a visit from some AstraZeneca reps, pushing Seroquel for bipolar depression and using some of the most asinine sales patter ever.

"Yes, until today, I was seeing reps a few times a month for 5 minute visits in order to keep up on trends in drug company marketing techniques. But today, an Astra Zeneca rep and his district manager came in to push Seroquel for bipolar depression. They came armed with the two studies that won Seroquel its FDA approval. The studies have their limitations, but somehow these reps didn't bring these up."

Those studies would be BOLDER I and BOLDER II, which CL Psych and I have had much fun carving up previously. A letter of mine challenging some of the statistics in BOLDER II will be published in the Journal of Clinical Psychopharmacology in June.

Back to Carlat:

"[W]hat I got was a ridiculous hard sell: 'Dr. Carlat, given this data, would you choose Seroquel over the other atypical antipsychotics for bipolar depression?' I asked them if Astra Zeneca had done any head-to-head studies comparing Seroquel with the others. The rep adopted a pseudo-confused look, and said, 'I'm not even sure that kind of study would be ethical--would the FDA even allow you to compare an approved drug with an unapproved drug?' I pointed out that the FDA, in fact, requires that drugs be compared with placebo, the ultimate in 'unapproved' drugs, and that they deem this ethical enough."

His encounter with the reps goes from there. Were these guys so dumb that they didn't know who they were dealing with in advance? Are reps still being taught and using that absurd Zerox sales training dialogue? I was smarter than that when I was a pharma rep 20 years ago.

As a result of the visit, Carlat has banned pharma reps from his office. Good for him. I wish other doctors would follow suit. I also wish doctors would be a hell of a lot more skeptical about how they hand out Seroquel. In my opinion, it is not a good drug for anything other than short-term use--and even in short-term use it's pretty nasty stuff. Your mileage may vary, however. I'll leave it at that.

Posted by Philip Dawdy at April 11, 2008 12:03 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

The reps I've met were talking pre-planned canned answers when I directed pointed questions at them in the patient waiting area. Taken aback, after realizing I was asking questions [a doctor might?]he shut up.

I encountered a AstraZeneca rep in a hospital pushing Seroquel for Borderline.

I also recently had a talk w my own psych and suggested they stop handing out Seroquel as samples and consider it a controlled substance; considering the QBALL, and abuse in prisons to start for reason, besides having street value.

I do believe we have entered the antipsychotic for all ailments arena and it isn't going to go away. I hope ppl. watch their backs for walking out of offices with MDD with Seroquel or Abilify in their hands.

Posted by: Stephany at April 11, 2008 02:01 AM

Agree with your remarks, Stephany. I was waiting with a friend who was to see her doctor down in Raleigh the other day. Apparently two reps came in and my friend didn't tell me, fearful for what I might say or do. I guess she made a good choice.

Posted by: Sorrowful at April 11, 2008 11:38 AM

I won't ever take Seroquel if I can help it, but I know quite a few folks with bipolar disorder who use it as a maintenance medication and say it is the best thing they've found. So I have to think it has its legitimate uses - just not as a first resort.

Philip, when you say in your previous post that 2-3% of U.S. children are on antipsychotics, where does that statistic come from? I gather David Healy said something along those lines but where did he get his numbers? If it's true then that is very disturbing - all the more reason to know where the data are coming from.

Posted by: Garth at April 11, 2008 12:18 PM

"A letter of mine challenging some of the statistics in BOLDER II will be published in the Journal of Clinical Psychopharmacology in June."

Congratulations, that's awesome!

Posted by: Stephany at April 13, 2008 01:36 PM
Post a comment









Remember personal info?






pic1.jpg

Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Search


Recent Entries
$99 Left
$114 To Go
Winter Fundraiser, $134 To Go, Final Day
Ruth Lilly, Eli Lilly Heiress, Prozac Beneficiary Dies At 94
Winter Fundraiser, Final Day, Less Than $200 To Go
UCLA Psychiatrist Criticizes DSM-5
Winter Fundraiser, Barely $200 To Go
Most Popular Posts Of 2009
Winter Fundraiser, Less Than $300 Left, Let's Wrap It Up
Senate Health Care Bill Contains $1.25 Billion Gift To Sen. Stabenow
Travel Day, Comment Approval May Be Intermittent
Winter Fundraiser, Close But Stalled
Senate Health Care Reform Bill Contains Controversial MOTHERS Act, Abortion Study
Adult ADHD And Sleep Problems
Vic Chesnutt Dead At 45, Possible Suicide
Recent Comments

Stephany on Psychiatrist Bans Sales Reps After Seroquel Reps Visit

Garth on Psychiatrist Bans Sales Reps After Seroquel Reps Visit

Sorrowful on Psychiatrist Bans Sales Reps After Seroquel Reps Visit

Stephany on Psychiatrist Bans Sales Reps After Seroquel Reps Visit

Archives
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Powered by
Movable Type 3.2